Auro Pharma: 734-714 May Be A Good Demand Zone; Strong Pipelines Of US ANDA Approvals & USD May Help

Trading/Investment Idea: Auro Pharma

CMP: 746

Buy on dips around: 734-724;

TGT: 760-785*-830-895*-925-956-1005-1065 (1-3/12M)

TSL< 710

Note: Consecutive closing (3 days) below 710 for any reason, Auro Pharma may further fall up to 690-675* & 640-600-580 and 490 in the near to long term (alternative bear case scenario).

For Auro Pharma (Consolidated):

Q4FY16 TTM EPS: 33.92 (FY:16/Actual)

Projected FWD EPS: 42.25-52.50-66.75 (FY:17-19/Estimated)

Average PE: 20

Present intrinsic value may be around: 680 (FY:16/TTM)

Projected fair value may be around: 850-1050-1335 (FY:17-19/FWD)

As par BG metrics & current market parameters (keeping in view both technical & fundamental factors): Trading Purpose

Present median valuation may be around: 710 (FY:16/TTM)

Projected fair valuations might be around: 795-885-995 (FY:17-19/FWD)

 

AUROPHARMA	EPS	BV	P/E	Low	High	Median	200-DEMA	10-DEMA
Q4FY16/TTM	33.92	91.02	20	711.67	705.92	708.80	746.58	734.55
FY17/FWD	42.25	122.45	20	794.27	787.84	791.05	746.58	734.55
FY18/FWD	52.5	165.95	20	885.39	878.22	881.81	746.58	734.55
FY19/FWD	66.75	224.15	20	998.34	990.26	994.30	746.58	734.55

Analytical Charts:

Article Courtesy: Frontiza.com